SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001013762-23-002876
Filing Date
2023-10-10
Accepted
2023-10-10 17:00:43
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea186266-s3_allaritythera.htm S-3 249714
2 OPINION OF LEWIS BRISBOIS BISGAARD & SMITH LLP ea186266ex5-1_allaritythera.htm EX-5.1 11553
3 CONSENT OF WOLF & COMPANY, P.C. ea186266ex23-1_allaritythera.htm EX-23.1 2038
4 CALCULATION OF FILING FEE TABLE ea186266ex-fee_allaritythera.htm EX-FILING FEES 10257
5 GRAPHIC image_001.jpg GRAPHIC 6581
6 GRAPHIC image_002.jpg GRAPHIC 24268
7 GRAPHIC ex5-1_001.jpg GRAPHIC 8092
  Complete submission text file 0001013762-23-002876.txt   328546
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274923 | Film No.: 231318634
SIC: 2834 Pharmaceutical Preparations